Latest news from American Society for Radiation Oncology (ASTRO) on Newswise en-us Copyright 2024 Newswise 115 31 / /images/newswise-logo-rss.gif /articles/2024-multidisciplinary-head-and-neck-cancers-symposium-to-be-held-in-phoenix-and-online-feb-29-mar-2/?sc=rsin /articles/2024-multidisciplinary-head-and-neck-cancers-symposium-to-be-held-in-phoenix-and-online-feb-29-mar-2/?sc=rsin Wed, 31 Jan 2024 07:45:48 EST The 2024 Multidisciplinary Head and Neck Cancers Symposium will take place February 29 to March 2 in Phoenix and via livestream for virtual attendees. American Society for Radiation Oncology (ASTRO) /articles/radiation-oncology-physician-groups-unite-to-ensure-patient-access-to-cancer-care/?sc=rsin /articles/radiation-oncology-physician-groups-unite-to-ensure-patient-access-to-cancer-care/?sc=rsin Tue, 09 Jan 2024 08:00:30 EST Today, the largest professional societies representing radiation oncology physicians in the United States announced a partnership with the goal of reforming radiation oncology Medicare payments to expand and enhance access to high quality care for people with cancer. American Society for Radiation Oncology (ASTRO) /articles/american-society-for-radiation-oncology-astro-ceo-laura-thevenot-announces-2024-retirement/?sc=rsin /articles/american-society-for-radiation-oncology-astro-ceo-laura-thevenot-announces-2024-retirement/?sc=rsin Mon, 08 Jan 2024 14:30:56 EST The American Society for Radiation Oncology (ASTRO) today announced that CEO Laura Thevenot plans to retire at the end of 2024 after leading the organization since 2002. During Thevenot's tenure at ASTRO, membership grew by over 50% to its current level of more than 10,500 physicians, biologists, physicists, radiation therapists, dosimetrists and other health care professionals. Additionally, the association's professional staff expanded from 18 in 2002 to more than 80 currently. American Society for Radiation Oncology (ASTRO) /articles/dr-rachel-jimenez-named-editor-in-chief-of-advances-in-radiation-oncology-astro-s-open-access-journal/?sc=rsin /articles/dr-rachel-jimenez-named-editor-in-chief-of-advances-in-radiation-oncology-astro-s-open-access-journal/?sc=rsin Wed, 06 Dec 2023 12:05:48 EST The American Society for Radiation Oncology (ASTRO) announced today that Rachel Jimenez, MD, will become the new editor-in-chief of Advances in Radiation Oncology, ASTRO's gold open access journal. Dr. Jimenez, an associate professor of radiation oncology at Harvard Medical School and the chair of quality and safety in radiation oncology at Mass General Cancer Center, will begin her five-year term in March 2024. Dr. Jimenez will succeed Robert C. Miller, MD, MBA, FASTRO, who has served as editor-in-chief since the journal was founded in 2015. American Society for Radiation Oncology (ASTRO) /articles/astro-applauds-appointment-of-dr-w-kimryn-rathmell-as-national-cancer-institute-director/?sc=rsin /articles/astro-applauds-appointment-of-dr-w-kimryn-rathmell-as-national-cancer-institute-director/?sc=rsin Thu, 30 Nov 2023 10:45:43 EST The American Society for Radiation Oncology (ASTRO) today expressed its support for President Joe Biden's intended appointment of W. American Society for Radiation Oncology (ASTRO) /articles/astro-issues-patient-centered-clinical-guideline-on-partial-breast-irradiation-for-early-stage-invasive-breast-cancer-and-dcis/?sc=rsin /articles/astro-issues-patient-centered-clinical-guideline-on-partial-breast-irradiation-for-early-stage-invasive-breast-cancer-and-dcis/?sc=rsin Wed, 15 Nov 2023 11:00:28 EST The American Society for Radiation Oncology (ASTRO) issued today a clinical guideline on partial breast irradiation for patients with early-stage invasive breast cancer or ductal carcinoma in situ (DCIS). American Society for Radiation Oncology (ASTRO) /articles/medicare-physician-payment-final-rule-cements-more-cuts-to-radiation-oncology-underscores-need-for-legislative-fix/?sc=rsin /articles/medicare-physician-payment-final-rule-cements-more-cuts-to-radiation-oncology-underscores-need-for-legislative-fix/?sc=rsin Thu, 02 Nov 2023 16:05:12 EST The American Society for Radiation Oncology (ASTRO) issued the following statement in response to the final 2024 Medicare Physician Fee Schedule (MPFS) released today: "ASTRO is deeply disappointed that CMS finalized an additional 2% cut to reimbursement for radiation therapy in today's MPFS final rule. American Society for Radiation Oncology (ASTRO) /articles/astro-celebrates-contributions-to-radiation-oncology-with-2023-gold-medals-and-other-awards/?sc=rsin /articles/astro-celebrates-contributions-to-radiation-oncology-with-2023-gold-medals-and-other-awards/?sc=rsin Thu, 26 Oct 2023 14:05:14 EST The American Society for Radiation Oncology (ASTRO) recognized the recipients of its 2023 Gold Medal awards and other high-profile honors during an awards ceremony at the 65th ASTRO Annual Meeting in San Diego. Photos from the ceremony are available online. American Society for Radiation Oncology (ASTRO) /articles/using-recent-diagnostic-scans-can-substantially-cut-time-to-treatment-for-patients-needing-urgent-palliation/?sc=rsin /articles/using-recent-diagnostic-scans-can-substantially-cut-time-to-treatment-for-patients-needing-urgent-palliation/?sc=rsin Tue, 03 Oct 2023 12:00:00 EST Using previously taken diagnostic computed tomography (CT) scans in place of CT simulation scans to plan simple palliative radiation treatments can substantially reduce the time some people spend waiting for urgent treatment, improving the patient experience, a new study suggests. American Society for Radiation Oncology (ASTRO) /articles/liquid-biopsy-may-help-identify-which-patients-with-non-small-cell-lung-cancer-will-benefit-most-from-radiation/?sc=rsin /articles/liquid-biopsy-may-help-identify-which-patients-with-non-small-cell-lung-cancer-will-benefit-most-from-radiation/?sc=rsin Mon, 02 Oct 2023 14:25:00 EST A novel liquid biopsy test may help determine which patients with non-small cell lung cancer that has spread beyond the lungs are most likely to benefit from targeted, high-dose radiation, rather than drug-based therapy, a new study suggests. American Society for Radiation Oncology (ASTRO) /articles/accelerated-radiation-treatment-could-reduce-head-and-neck-cancer-patient-burden-in-low-and-middle-income-countries/?sc=rsin /articles/accelerated-radiation-treatment-could-reduce-head-and-neck-cancer-patient-burden-in-low-and-middle-income-countries/?sc=rsin Mon, 02 Oct 2023 14:00:00 EST A type of head and neck cancer predominantly diagnosed in people who reside in low- and middle-income countries may be treated effectively with fewer, but higher doses of radiation, a large new international study suggests. American Society for Radiation Oncology (ASTRO) /articles/precision-medicine-navigators-increase-genomic-testing-rates-for-black-patients-with-prostate-cancer/?sc=rsin /articles/precision-medicine-navigators-increase-genomic-testing-rates-for-black-patients-with-prostate-cancer/?sc=rsin Sun, 01 Oct 2023 19:55:00 EST The presence of a clinical navigator to act as a liaison between people with prostate cancer and the health care system greatly increases the likelihood that patients, especially Black patients, will receive advanced testing that can help predict the severity of their disease and guide treatment, a new study suggests. American Society for Radiation Oncology (ASTRO) /articles/short-course-radiation-as-effective-as-standard-treatment-for-patients-who-opt-for-breast-reconstruction-after-mastectomy/?sc=rsin /articles/short-course-radiation-as-effective-as-standard-treatment-for-patients-who-opt-for-breast-reconstruction-after-mastectomy/?sc=rsin Sun, 01 Oct 2023 13:20:00 EST In a first-of-its-kind study, people with breast cancer who underwent implant-based breast reconstruction immediately following a mastectomy reported that getting fewer, higher doses of radiation was just as effective as standard radiation, did not increase side effects and saved them time and money. American Society for Radiation Oncology (ASTRO) /articles/high-dose-radiation-offers-new-treatment-option-for-older-patients-with-inoperable-kidney-tumors/?sc=rsin /articles/high-dose-radiation-offers-new-treatment-option-for-older-patients-with-inoperable-kidney-tumors/?sc=rsin Sun, 01 Oct 2023 12:50:00 EST Older adults diagnosed with kidney tumors that are not suitable for surgery may benefit from targeted, high-dose radiation, a new study from Australian and Dutch researchers suggests. American Society for Radiation Oncology (ASTRO) /articles/sexual-activity-and-vaginal-dilation-associated-with-fewer-side-effects-after-cervical-cancer-treatment/?sc=rsin /articles/sexual-activity-and-vaginal-dilation-associated-with-fewer-side-effects-after-cervical-cancer-treatment/?sc=rsin Sun, 01 Oct 2023 12:40:00 EST People who engage in sexual activity or vaginal dilation after chemoradiation treatment for cervical cancer are at lower risk for long-term side effects, according to a new study from researchers in Austria. American Society for Radiation Oncology (ASTRO) /articles/liquid-biopsies-can-rapidly-detect-residual-disease-following-cervical-chemoradiation-study-finds/?sc=rsin /articles/liquid-biopsies-can-rapidly-detect-residual-disease-following-cervical-chemoradiation-study-finds/?sc=rsin Sun, 01 Oct 2023 11:00:00 EST Two liquid biopsy tests that look for the presence of human papillomavirus (HPV) in the blood accurately identified patients with a high risk of cervical cancer recurrence after the completion of chemoradiation, a new study confirms. American Society for Radiation Oncology (ASTRO) /articles/high-cure-rate-low-toxicity-maintained-with-shortened-radiation-treatment-for-intermediate-risk-prostate-cancer-study-finds/?sc=rsin /articles/high-cure-rate-low-toxicity-maintained-with-shortened-radiation-treatment-for-intermediate-risk-prostate-cancer-study-finds/?sc=rsin Fri, 29 Sep 2023 17:00:00 EST People with intermediate risk, localized prostate cancer can be treated as effectively using fewer and higher doses of radiation therapy delivered over five treatment sessions as they can with lower doses delivered over several weeks, a new phase III randomized trial suggests. American Society for Radiation Oncology (ASTRO) /articles/winners-of-the-astro-sumitomo-pharma-pfizer-alliance-new-combination-therapy-challenge-announced/?sc=rsin /articles/winners-of-the-astro-sumitomo-pharma-pfizer-alliance-new-combination-therapy-challenge-announced/?sc=rsin Wed, 27 Sep 2023 07:00:33 EST The American Society for Radiation Oncology (ASTRO) today announced the three winning research proposals for the 2022 ASTRO-Myovant Sciences (now known as Sumitomo Pharma)-Pfizer Alliance New Combination (Relugolix-Radiation) Therapy Challenge. American Society for Radiation Oncology (ASTRO) /articles/radiation-oncology-research-and-clinical-trial-results-to-be-featured-at-astro-s-annual-meeting-in-san-diego/?sc=rsin /articles/radiation-oncology-research-and-clinical-trial-results-to-be-featured-at-astro-s-annual-meeting-in-san-diego/?sc=rsin Wed, 13 Sep 2023 07:15:34 EST The American Society for Radiation Oncology (ASTRO) announced today the 10 studies to be highlighted in the 2023 ASTRO Annual Meeting press program. Researchers will discuss their findings in news briefings held October 2 and 3 at the San Diego Convention Center and via live webcast. American Society for Radiation Oncology (ASTRO) /articles/astro-president-to-speak-at-president-s-cancer-panel-meeting-about-radiation-oncology-s-critical-contributions-to-national-goals/?sc=rsin /articles/astro-president-to-speak-at-president-s-cancer-panel-meeting-about-radiation-oncology-s-critical-contributions-to-national-goals/?sc=rsin Thu, 07 Sep 2023 07:10:39 EST American Society for Radiation Oncology (ASTRO) President Jeff Michalski, MD, MBA, FASTRO, will join today's first stakeholder meeting of the President's Cancer Panel. Dr. Michalski was invited to share how ASTRO and the radiation oncology community are contributing to the National Cancer Plan. Radiation therapy contributes to 40% of global cancer cures, and more than a million Americans receive radiation treatments for cancer each year. American Society for Radiation Oncology (ASTRO)